Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer

Acta Oncol. 2017 Aug;56(8):1136-1138. doi: 10.1080/0284186X.2017.1299221. Epub 2017 Mar 8.

Authors

Affiliations

¹ a Department of Radiation Medicine , Georgetown University Hospital , Washington , DC , USA.
² b Department of Radiation Oncology , The Valley Health Hospital , Ridgewood , NJ , USA.
³ c Department of Medical Physics , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
⁴ d Department of Urology , Georgetown University Hospital , Washington , DC , USA.

PMID: 28270015
DOI: 10.1080/0284186X.2017.1299221

No abstract available

Publication types

Letter

MeSH terms

Acute Disease
Androgen Antagonists / therapeutic use
Antineoplastic Agents, Hormonal / therapeutic use
Combined Modality Therapy
Humans
Male
Organ Size
Prognosis
Prostate / pathology
Prostatic Neoplasms / diagnosis
Prostatic Neoplasms / drug therapy
Prostatic Neoplasms / pathology
Prostatic Neoplasms / radiotherapy*
Radiation Injuries / diagnosis*
Radiation Injuries / etiology
Radiation Injuries / pathology
Radiosurgery / adverse effects*
Radiotherapy Dosage
Retrospective Studies
Risk Factors
Tumor Burden
Urinary Bladder / pathology
Urinary Bladder / radiation effects
Urologic Diseases / diagnosis*
Urologic Diseases / etiology

Substances

Androgen Antagonists
Antineoplastic Agents, Hormonal